2008 - Review: Systemic corticosteroids, antibiotics, and noninvasive positive pressure ventilation are effective in acute COPD
- British Thoracic Society survey of knowledge of healthcare professionals managing patients with acute hypercapnic exacerbation of chronic obstructive pulmonary disease requiring non-invasive ventilation. Ballard, E.; McDonnell, L.; Keilty, S.; Davidson, A. C.; Hart, N. // Thorax;Sep2011, Vol. 66 Issue 9, p823
A letter to the editor is presented in response to the article regarding the use of non-invasive ventilation (NIV) in acute hypercapnic exacerbations of chronic obstructive pulmonary disease.
- Treatment Comparison of Budesonide/ Formoterol with Salmeterol/Fluticasone Propionate in Adults Aged â‰¥16 Years with Asthma: Post Hoc Analysis of a Randomized, Double-Blind Study. Kuna, Piotr // Clinical Drug Investigation;2010, Vol. 30 Issue 9, p565
Background: Three fixed maintenance-dose inhaled corticosteroid/long-acting Î²2-agonist (ICS/LABA) combinations for the treatment of asthma are currently available: salmeterol/fluticasone propionate (Seretideâ„¢/Advairâ„¢/ Adoairâ„¢) budesonide/formoterol (SymbicortÂ®) and...
- COPD exacerbations Â· 5: Management. Rodríguez-Roisin, R. // Thorax;Jun2006, Vol. 61 Issue 6, p535
The article presents a review of the most crucial evidence based therapeutic options for the management of exacerbations of Chronic Obstructive Pulmonary Disease (COPD). Exacerbations of COPD have the characteristics of enhanced airway inflammation and oedema and systemic inflammation, leading...
- Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study. Roede, B. M.; Bresser, P.; Bindels, P. J. E.; Kok, A.; Prins, M.; tel Riet, G.; Geskus, R. B.; Herings, R. M. C.; Prins, J. M. // Thorax;Nov2008, Vol. 63 Issue 11, p968
Objectives: The risk of a subsequent exacerbation after treatment of an exacerbation with oral corticosteroids without (OS) or with (USA) antibiotics was evaluated in a historical population based cohort study comprising patients using maintenance medication for obstructive lung disease....
- Skeletal muscle ergoreflex overactivity is not related to exercise ventilatory inefficiency in non-hypoxaemic patients with COPD. Nakamoto, Fernanda Patti; Neder, J. Alberto; Maia, Joyce; Andrade, Marília S.; Silva, Antônio Carlos // European Journal of Applied Physiology;Dec2007, Vol. 101 Issue 6, p705
Increased ventilatory response to the metabolic demand (â€œventilatory inefficiencyâ€) is commonly found during dynamic exercise in patients with chronic obstructive pulmonary disease (COPD). However, the role of enhanced muscle ergoreflex activity on this phenomenon is yet unknown. Ten...
- Benefits and Risks of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. Bonay, M.; Bancal, C.; Crestani, B. // Drug Safety;2002, Vol. 25 Issue 1, p57
Inhaled corticosteroids have a proven benefit in the management of asthma, but until recently, their efficacy in non-asthmatic, smoking-related chronic obstructive pulmonary disease (COPD) was not evidence-based. Airway inflammation in COPD differs from inflammation in asthma. Some studies have...
- Inhaled corticosteroids and COPD exacerbations. Kuritzky, Louis // Internal Medicine Alert;3/29/2010, Vol. 32 Issue 6, p48
The article reports on the effectiveness of inhaled corticosteroids (ICS) in treating acute exacerbations of chronic obstructive pulmonary disease (AC-COPD).
- High-dose steroids cut COPD deaths. Polak, Monika // GP: General Practitioner;2/3/2003, p17
Reports on a study published in the 'European Respiratory Journal' stating that treating patients with medium and high dose of inhaled corticosteroids after discharge from hospital from chronic obstructive pulmonary disease (COPD) have a lower risk of deaths. Doses of steroids for patients with...
- Discontinuing Inhaled Steroids in COPD Patients. Carter, Chuck // American Family Physician;4/15/2003, Vol. 67 Issue 8, p1803
Discusses the study 'Effect of Discontinuation of Inhaled Corticosteroids in Patients With Chronic Obstructive Pulmonary Disease,' by P. Van der Valk et al., from the November 15, 2002 issue of the 'American Journal of Respiratory and Critical Care Medicine.'